DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Anupam Rasayan India Limited — Acquisition (including agreement to acquire)-XBRL

NSE 1 hr ago·29 Sept 2026, 4:21 pm

Anupam Rasayan India

Anupam Rasayan India Limited has informed stock exchanges about the execution of an agreement to acquire a business or stake. This acquisition is a strategic move to expand the company's operations or market presence.

For investors, this news signals a potential growth phase for the company. It indicates that the management is actively seeking opportunities to strengthen its portfolio and increase its competitive edge in the industry.

Investors should watch for further details on the target company, the financial implications of the deal, and the timeline for completion. These factors will be crucial in assessing the long-term impact on the company's performance and stock value.